A British-American dealer dubbed the "Ketamine Queen" who sold the drugs that killed "Friends" star Matthew Perry, and boasted she supplied an elite circle of Hollywood VIPs, was jailed for 15 years….

A British-American dealer dubbed the "Ketamine Queen" who sold the drugs that killed "Friends" star Matthew Perry, and boasted she supplied an elite circle of Hollywood VIPs, was jailed for 15 years on Wednesday.

One of your browser extensions seems to be blocking the video player from loading.

To watch this content, you may need to disable it on this site.

Jasveen Sangha, 42, was one of five people charged over the death of the beloved Canadian-American actor, who was found unresponsive in the hot tub of his luxury Los Angeles home in 2023.

Sangha, a dual citizen of the United States and Britain, ran a drugs emporium from her swanky apartment in Los Angeles, from where she dished out narcotics to wealthy customers in America's entertainment capital.

"To cultivate her business, (Sangha) marketed herself as an exclusive dealer who catered to high-profile Hollywood clientele," prosecutors wrote in sentencing papers.

"As she told one customer in 2020, 'I'm really select with people,' and 'it's a very VIP circle of celebs.'".

Sangha worked with a middleman, Erik Fleming, to sell 51 vials of ketamine to Perry's live-in personal assistant, Kenneth Iwamasa.

Iwamasa repeatedly injected Perry with the ketamine that she had supplied, including on October 28, 2023, when he administered at least three shots of Sangha's drugs, which killed the actor.

When Sangha heard news reports about Perry's sudden death, she tried to cover her tracks.

Sangha's actions "show a cold callousness and disregard for life.

She chose profits over people, and her actions have caused immense pain to the victims' families and loved ones," prosecutors wrote.

For markets and businesses, the practical impact depends on final numbers, regulatory filings, company disclosures and broader investor sentiment once the trading day or reporting cycle is complete.

For households, investors and policymakers, the final effect becomes clearer only when the headline is read with market closing data, regulator records, company statements and the wider macroeconomic setting.

The source page records the update at 09 Apr 2026, 01:11 AM, and the story should be followed for any later corrections or clarifications.